NASDAQ:BIB

Proshares Ultra Nasdaq Biotechnology ETF News

Financial Services > Asset Management

Buy BIB

*Your capital is at risk

$83.72

+1.06 (+1.29%)

At Close: Jun 15, 2026

FDA issues new guidance aimed at more efficient drug development

12:00am, Monday, 15'th Oct 2018

Marché : Quand des tweets font chuter ou bondir les cours de Bourse

10:54am, Friday, 28'th Sep 2018

(BFM Bourse) - Elon Musk, le fantasque patron de Tesla, n'est pas la seule personnalité à avoir réussi le tour de force d'influer sur des cours de Bourse en …

Artificial intelligence to play major role in healthcare - Reuters

12:00am, Friday, 31'st Aug 2018

European Court makes restrictive ruling on genome editing

12:00am, Monday, 30'th Jul 2018

Pfizer boosts prices of certain drugs by almost 10%

12:00am, Tuesday, 03'rd Jul 2018

FDA withdraws draft guidance related to biosimilar development

12:00am, Monday, 02'nd Jul 2018

Buffett, Dimon and Bezos name CEO for healthcare venture

12:00am, Wednesday, 20'th Jun 2018

FDA Ad Com Wednesday on molecular targets in pediatric cancer

12:00am, Monday, 18'th Jun 2018

Biotech industry group criticized for party featuring topless dancers

12:00am, Wednesday, 13'th Jun 2018

Trump set to sign "right to try" bill; biotechs rally

12:00am, Wednesday, 23'rd May 2018

Consider Waiting To Buy BIB

12:00am, Thursday, 05'th Apr 2018

Billions on the line as White House and insurers wait for appeals court decision on ACA payments

12:00am, Thursday, 15'th Mar 2018

Biogen, Neurotrope, Anavex And The Future Of Alzheimer's Treatments

12:00am, Thursday, 01'st Mar 2018

Will healthcare stocks hold steady amidst broad selloff?

12:00am, Monday, 05'th Feb 2018

The Passive/Aggressive Portfolio

12:00am, Friday, 19'th Jan 2018

Proshares Ultra Nasdaq Biotechnology ETF News

FDA issues new guidance aimed at more efficient drug development

Marché : Quand des tweets font chuter ou bondir les cours de Bourse

Artificial intelligence to play major role in healthcare - Reuters

European Court makes restrictive ruling on genome editing

Pfizer boosts prices of certain drugs by almost 10%

FDA withdraws draft guidance related to biosimilar development

Buffett, Dimon and Bezos name CEO for healthcare venture

FDA Ad Com Wednesday on molecular targets in pediatric cancer

Biotech industry group criticized for party featuring topless dancers

Trump set to sign "right to try" bill; biotechs rally

Consider Waiting To Buy BIB

Billions on the line as White House and insurers wait for appeals court decision on ACA payments

Biogen, Neurotrope, Anavex And The Future Of Alzheimer's Treatments

Will healthcare stocks hold steady amidst broad selloff?

The Passive/Aggressive Portfolio

Top Fintech Company